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Abstract
Introduction Interleukin (IL)-18 is a key modulator of the
cytokine response that leads to organ dysfunction and
prolonged intensive care unit (ICU) stay after cardiopulmonary
bypass surgery. We hypothesised that variation in the pro-
inflammatory gene IL-18 is associated with adverse clinical
outcome because of a more intense inflammatory response.
Methods Haplotypes of the IL-18 gene were inferred from
genotypes of 23 Coriell Registry subjects. Four haplotype tag
single nucleotide polymorphisms (-607 C/A, -137 G/C, 8148
C/T and 9545 T/G) identified four major haplotype clades.
These polymorphisms were genotyped in 658 Caucasian
patients undergoing cardiopulmonary bypass surgery. Clinical
phenotypes were collected by retrospective chart review.
Results Patients homozygous for the T allele of the 9545 T/G
polymorphism had an increased occurrence of prolonged ICU
stay (6.8% for TT genotype versus 2.7% for GG or GT
genotype; p = 0.015). Patients homozygous for the T allele also
had increased occurrence of low systemic vascular resistance
index (62%) compared with the GG and GT genotypes (53%;
p = 0.045). Patients homozygous for the T allele had increased
serum IL-18 concentrations 24 hours post-surgery (p = 0.018),
increased pro-inflammatory tumour necrosis factor alpha
concentrations (p = 0.014) and decreased anti-inflammatory
serum IL-10 concentrations (p = 0.018) 24 hours post-surgery.
Conclusions The TT genotype of the IL-18 9545 T/G
polymorphism is associated with an increased occurrence of
prolonged ICU stay post-surgery and greater post-surgical
inflammation. These results may be explained by greater serum
IL-18, leading to greater pro-versus anti-inflammatory cytokine
expression.
Introduction
The balance of pro-inflammatory (e.g. tumour necrosis factor
alpha (TNF-α)) and anti-inflammatory (e.g. interleukin (IL)-10)
cytokine gene expression is highly correlated with organ dys-
function and adverse outcome after cardiopulmonary bypass
(CPB) surgery [1]. IL-18 is a key cytokine regulator of this bal-
ance that, among other clinical and cytokine measures, stands
out as predictive of organ dysfunction and adverse outcomes
after CPB [2]. IL-18 acts with IL-12 in a synergistic fashion to
stimulate the release of interferon-gamma (IFN-γ) from lym-
phocytes [3]. High serum levels of IL-18 are associated with
increased production of the pro-inflammatory cytokine TNF-α
[4] and decreased production of the anti-inflammatory
cytokine IL-10 [5]. Serum levels of IL-18 increase in response
to CPB surgery [2] and in other inflammatory conditions such
as sepsis [6] and type 1 diabetes [7].
Inflammatory gene polymorphisms have been linked to the
intensity of the post-operative inflammatory response and to
clinical outcomes after CPB surgery [8]. Therefore, we postu-
lated that IL-18 gene single nucleotide polymorphisms (SNPs)
may be important in recovery from CPB surgery. Two polymor-
phic loci within the IL-18 gene have been investigated for
associations between genotype and serum concentrations of
IL-18 (intermediate phenotype) as well as associations
between genotype and clinical outcome (phenotype). The -
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607 C/A and -137 G/C SNPs were initially discovered to influ-
ence promoter activity of the IL-18 gene [9]. The -137 C allele
has been associated with adverse outcomes and higher serum
IL-18 cytokine levels, and the -607 A allele has been associ-
ated with improved outcomes and lower serum IL-18 levels in
type 1 diabetes [3].
Our study design was based on the above observation that
increased serum IL-18 is associated with adverse outcomes
after CPB, including cardiovascular dysfunction [2], associ-
ated with increased serum TNF-α and decreased serum IL-10
[10]. Therefore, we tested the hypothesis that IL-18 gene pol-
ymorphisms are associated with adverse outcome, as meas-
ured by prolonged stays in the intensive care unit (ICU)
(primary clinical outcome) and cardiovascular dysfunction
(secondary clinical outcome). We then confirmed that the pol-
ymorphism is associated with increased serum concentrations
of IL-18 and altered serum concentrations of TNF-α and IL-10
post-CPB, thus providing a possible explanation for our clini-
cal results.
Materials and methods
Patient cohort
All patients admitted to the cardiac surgery ICU of St Paul's
Hospital in Vancouver having elective CPB surgery between
February 2001 and December 2003 were eligible for entry
into this study. For inclusion, 890 were screened, of which
815 had CPB pump-driven circulation of blood during first-
time elective coronary artery bypass surgery. Of these, we
restricted our analyses to the 658 patients who were Cauca-
sian in order to decrease the potentially confounding influence
of population admixture secondary to ethnic diversity on asso-
ciations between genotype and phenotype. All 658 patients
were successfully genotyped for four polymorphisms in the IL-
18 gene and made up our final cohort for analysis.
Our Research Ethics Board approved analysis of fully anony-
mous data and, for DNA samples, collection of blood that was
being discarded as part of routine clinical care in a consecu-
tive cohort of all patients meeting inclusion criteria and admit-
ted to our cardiac surgical ICU. Using this fully anonymous
study design the Research Ethics Board of Providence Health
Care and the University of British Columbia approved this
study and waived informed consent.
Primary clinical phenotype
This cohort was confined to patients undergoing first-time
elective coronary artery bypass surgery, so a mortality rate
endpoint would be ineffective unless sample sizes were very
large. Many authors, therefore, use prolonged ICU stay as a
measure of adverse outcome [11,12]. Most recently, Nakasuji
and colleagues found that prolonged ICU stay of more than
three days was a sensitive and specific measure of adverse
outcome that reflected measures of cardiovascular and pulmo-
nary organ failure [11]. Lawrence and colleagues found that
the Parsonnet score with a maximum predictive efficiency was
a score of 10. Patients having a Parsonnet score of 0 to 9 had
a mean ICU stay of about 1.5 days, while those having a score
of 10 or more had a mean ICU stay of about three days [12].
Therefore, we used the proportion of patient having a post-
operative ICU stay of greater than or equal to three days (72
hours) as our primary outcome variable. In our institution, the
decision to discharge patients from the ICU after CPB surgery
is protocol driven and genotype was unknown to care provid-
ers, making this measurement an unbiased outcome measure-
ment for this study, particularly because genotype was fully
blinded and not measured until after complete clinical data
had been collected.
Secondary clinical phenotype
Kristof and Magder [13] identified low post-CPB systemic vas-
cular resistance index (SVRI) as a clinical manifestation of sys-
temic inflammation. This vasodilatory syndrome is associated
with related parameters such as longer cross-clamp times and
lower post-CPB platelet count [13]. We used Kristof and
Magder's definition of two consecutive SVRI measurements
less than 1800 dyne.s/cm5/m2 (SVRI = ((MAP-CVP) × 80)/CI,
where MAP is the mean arterial pressure, CVP is the central
venous pressure and CI is the cardiac index) as a secondary
clinical phenotype.
Intermediate phenotype
Serum concentrations of cytokines are useful intermediate
phenotypes to test for biologically plausible explanations for
genotype – clinical phenotype associations. We measured
serum IL-18, TNF-α and IL-10 concentrations in an overlap-
ping subset of patients (n = 44) within the current cohort for
whom serum was available from a related observational study.
Inclusion and exclusion criteria for this cohort were identical.
In our own preliminary time course experiments we found that
serum IL-18 concentrations peaked at 24 hours post-CPB.
Therefore, we measured serum IL-18, TNF-α and IL-10 at this
post-operative time point. Serum IL-18 and TNF-α were meas-
ured by ELISA (R&D Systems, Minneapolis, MN for IL-18; BD
PharMingen, San Diego, CA for TNF-α). Serum IL-10 was
measured using the Luminex bead-based bioassay system
(Luminex Corp, Austin, TX).
Tag single nucleotide polymorphism selection
To determine IL-18 gene haplotypes we used unphased gen-
otype data from the University of Arizona's Innate Immunity
Program in Genomics Application website. We used PHASE
v 2.0 [14] to infer haplotype from unphased genotype data.
The resulting haplotypes were clustered into four groups of
similar haplotypes (clades) using the molecular evolutionary
genetic analysis software package MEGA2 [15]. The program
LDSelect [16] was used to select a set of maximally informa-
tive haplotype tag (ht) SNPs with the restriction that the litera-
ture SNPs -607 C/A and -137 G/C be included. Four htSNPs
were chosen to differentiate the four haplotype clades: -607Available online http://ccforum.com/content/13/1/R9
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C/A (rs1946518), -137 G/C (rs187238), 8148 C/T
(rs360722) and 9545 T/G (rs5744249) (Figure 1).
Genotyping
DNA was extracted from peripheral blood samples using a
QIAamp DNA Blood Maxi Kit (Qiagen Inc. Canada, Missis-
sauga, ON, Canada). SNP genotypes were determined using
the 5' nuclease, or Taqman PCR method (Applied Biosys-
tems; Foster City, CA, USA) [17]. These htSNPs were then
genotyped in the 658 patients of our cohort undergoing CPB.
Statistics
Differences in continuous variables were assessed using Stu-
dent's t-test for two groups or an analysis of variance for more
than two groups for normally distributed data, and a Mann-
Whitney U Test or Kruskal-Wallis H Test for non-normally dis-
tributed data. Fisher's exact test was used to test for signifi-
cant differences in discrete variables. Data are reported as
mean ± standard error (SE). A p ≤ 0.05 was taken to indicate
a significant difference. Analysis was performed using SPSS
v11.5 (SPSS, Chicago, IL, USA). Allele frequencies were
tested for Hardy-Weinberg equilibrium using the test of Guo
Figure 1
Haplotypes of the IL-18 gene Haplotypes of the IL-18 gene. a) Haplotype diagram of the interleukin (IL)-18 gene. Haplotypes were inferred from unphased genotype data of 
23 unrelated healthy Caucasians by the PHASE v2.0 program. Each column represents a polymorphic locus in the IL-18 gene, and is coded as 
either the common allele (black square) or the rare allele (white square). The position of each polymorphic locus relative to the start site of translation 
is indicated at the top of the diagram. Each row indicates a unique haplotype inferred from genotype data. The clustering of similar haplotypes into 
clades is done as per the phylogenetic relation among haplotypes given by the MEGA2 software package. The positions chosen for genotyping (-
607, -137, 8148 and 9545) are indicated in the figure by bold numbering of the relative position and letter designations for the alleles within the dia-
gram. b) Haplotype diagram of the interleukin-18 gene in the patient population under study. Haplotypes were inferred from unphased geno-
type data of 658 unrelated Caucasians making up the study cohort using the PHASE v2.0 program. Allele and clade designations within the diagram 
are as in Figure 1a. Haplotype frequency within the patient cohort is indicated to the right of each haplotype. Only haplotype clades with frequency 
greater than 5% are represented.Critical Care    Vol 13 No 1    Shaw et al.
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and Thompson [18] and were all found to be in Hardy-Wein-
berg equilibrium.
Work by Long and Langley [19] indicates that on the order of
500 individuals are sufficient to detect the presence of causa-
tive polymorphisms having small effect on outcomes. Thus, we
have included 658 individuals in our study population.
Results
Selection of the 9545 T/G SNP
Using PHASE, we found four main haplotypes occurring at a
frequency greater than 5% in our patient cohort based on the
four chosen htSNPs (Figure 1b). As an initial screen, we exam-
ined the occurrence of our primary clinical outcome (pro-
longed ICU stay) by PHASE-inferred haplotype in our study
cohort. We found haplotypes 1 to 3 were associated with
greater occurrence of prolonged ICU stay (Figure 2). Haplo-
types 1 to 3 are uniquely tagged by the T allele of the 9545 T/
G polymorphism, so we focused on the 9545 T/G genotype
for further analyses. These data were best fit using a recessive
model (TT genotype compared to TG plus GG genotypes),
which was therefore used as the statistical analytic model
throughout the study. The TT genotype occurred in 58% of
patients. Genotypes of the 9545 T/G SNP were in Hardy
Weinberg equilibrium. No significant associations between
genotype and any clinical or intermediate phenotype were
observed for any of the three other htSNPs (data not shown).
Baseline and peri-operative characteristics
There were no significant differences between patients
homozygous for the T allele of the IL-18 9545 T/G SNP versus
patients having a GT or GG genotype in baseline characteris-
tics (Table 1) except for body mass index (BMI) (28 kg/m2 for
patients with TT genotype, 28 kg/m2 for patients with GT gen-
otype, 26 kg/m2 for patients with GG genotype, p = 0.022).
There were no significant differences by genotype in peri-oper-
ative management, including use of aprotinin (TT 15%,
GT+GG 10%, p = 0.10), amicar (TT 39%, GT+GG 38%, p =
0.99), or protamine (TT 0%, GT+GG 1%, p = 0.18) in our
study cohort. Similarly, there were no differences by genotype
in the use of vasodilators dobutamine (TT 71%, GT+GG 75%,
p = 0.25) or milrinone (TT 11%, GT+GG 13%, p = 0.47) in
the perioperative period. In addition there was no difference in
vasopressor use (receiving norepinephrine at 4, 12 and 24
hours: TT 7.8%, 5.2%, 2.1%, GT+GG 7.2%, 5.4%, 1.1%,
respectively).
Primary clinical phenotype
In our cohort of Caucasian patients who had CPB surgery,
patients homozygous for the T allele of the IL-18 9545 T/G
SNP had increased occurrence of prolonged ICU stay
(greater than 72 hours) after CPB surgery: 32 of 383 (8.4%)
for TT versus 10 of 275 (3.6%) for TG or GG (p = 0.015; Fig-
ure 3). The overall occurrence of prolonged ICU stay was 42
out of 658 patients (6.4%). These differences remained signif-
icant (p = 0.012) using logistic regression adjusted for age,
gender, duration of bypass and baseline organ function (ejec-
tion fraction, diabetes, renal dysfunction; Table 2). The sensi-
tivity of the TT genotype to predict prolonged ICU stay is (or
true positive rate) 76% and the specificity (or true negative
rate) is 43%.
Secondary clinical phenotype
In these Caucasian patients undergoing elective on-pump cor-
onary bypass graft surgery (CPB), those patients homozygous
for the T allele of the IL-18 9545 T/G SNP had increased fre-
quency of two consecutive SVRI measurements less than
1800 dyne.s/cm5/m2. The TT genotype was associated with
the increased frequency of two SVRI measurements less than
1800 (62%) compared with the GT+GG genotypes (53%)
(Figure 3). These differences remained significant (p = 0.045)
using logistic regression adjusted for age, gender and dura-
tion of bypass (Table 3). The difference in SVRI was not
accounted for by differences in post-operative use of vasodi-
lating inotropes or the vasopressor norepinephrine (above).
The fraction of patients having two or more Systemic Inflam-
matory Response Syndrome (SIRS) criteria at 24 hours was
24% in TT patients and 20.7% in GT+GG patients. The heart
rate component of SIRS scoring was significantly different
with TT patients having a heart rate at 24 hours of 78.4 ± 0.7
compared with 75.8 ± 0.7 for GT+GG patients (p = 0.016).
A trend to increased numbers of TT patients remaining on the
ventilator at 24 hours (TT 10.2%, GT+GG 8.3%), increased
numbers of patients having a rise in creatinine of more than 50
μmol/L at 24 hours (TT 4.1%, GT+GG 2.5%) and increased
mortality (TT 1.8%, GT+GG 1.1%) was observed, although
Figure 2
Prolonged intensive care unit (ICU) stay after cardiopulmonary bypass  (CPB) by interleukin (IL)-18 9545 T/G genotype in Caucasian patients  who underwent on-pump CPB surgery Prolonged intensive care unit (ICU) stay after cardiopulmonary 
bypass (CPB) by interleukin (IL)-18 9545 T/G genotype in Cauca-
sian patients who underwent on-pump CPB surgery. Percentage of 
patients having prolonged ICU stay (greater than 72 hours) are indi-
cated on the Y-axis and IL-18 genotype on the X-axis. Patients 
homozygous for the T allele of the IL-18 9545 T/G SNP had increased 
occurrence of prolonged ICU stay, compared with patients having a TG 
or GG genoytpe.Available online http://ccforum.com/content/13/1/R9
Page 5 of 8
(page number not for citation purposes)
the numbers of patients falling into these categories was too
low for these differences to be statistically significant.
Intermediate phenotype
In a subgroup of patients for whom serum cytokine measure-
ments were available, a significant difference was found in the
concentration of IL-18 24 hours post-CPB surgery by geno-
type of the IL-18 9545 T/G polymorphism. Patients
homozygous for the T allele had a significantly greater mean
serum IL-18 concentration (372 ± 24 pg/mL) compared with
those with the GT or GG genotypes (260 ± 48 pg/mL, p =
0.018; Figure 4).
A significant difference in serum concentration of TNF-α by IL-
18 9545 T/G genotype was observed 24 hours post-opera-
tively. Patients homozygous for the T allele of the IL-18 9545
T/G SNP had a significantly higher serum concentration of
TNF-α at this time point (314 ± 83 pg/mL) compared with all
other patients (67 ± 37 pg/mL, p = 0.014; Figure 4).
A significant difference in serum IL-10 levels was observed at
24 hours post-CPB by IL-18 9545 T/G genotype. Patients
homozygous for the T allele had significantly lower serum IL-10
levels 24 hours post-CPB (2.4 ± 1.0 pg/mL) compared with
all other patients (9.1 ± 2.8 pg/mL, p = 0.018; Figure 4).
Table 1
Baseline characteristics by IL-18 9545 genotype
9545 TT 9545 GT 9545 GG Total p value
Number (%) 383 (58) 225 (34) 50 (8) 658
Age (years) 65 ± 1 66 ± 1 66 ± 1 66 ± 1 0.655
Male sex (%) 77 77 70 76 0.544
Body mass index (kg/m2) 28 ± 1 28 ± 1 26 ± 1 28 ± 1 0.022
Ejection fraction (%) 49.2 ± 0.7 48.8 ± 0.9 51.3 ± 2.1 49.3 ± 0.5 0.529
Renal dysfunction (%) (Creatinine > 200 μmol/L) 3.6 2.2 0.0 2.9 0.266
Diabetes (Types I & II) (%) 29 28 27 28 0.969
Smoking (%) 32 41 36 32 0.129
Anti-hypertensive use (%) 65 61 58 62 0.495
Angiotensin-converting enzyme II inhibitor use (%) 48 54 50 52 0.447
Beta-blocker use (%) 58 60 56 59 0.745
Aspirin use (%) 59 59 60 59 0.992
Duration of surgery (hours) 4.4 ± 0.1 4.5 ± 0.1 4.4 ± 0.1 4.5 ± 0.1 0.728
Duration of bypass (hours) 1.8 ± 0.1 1.9 ± 0.1 1.8 ± 0.1 1.8 ± 0.1 0.544
Cross clamp time (hours) 1.3 ± 0.1 1.4 ± 0.1 1.4 ± 0.1 1.4 ± 0.1 0.143
Continuous variables are reported as mean ± standard error of the mean.
Figure 3
Prolonged intensive care unit (ICU) stay and low Systemic Vascular  Resistance Index (SVRI) after cardiopulmonary bypass (CPB) by inter- leukin (IL)-18 9545 T/G genotype in Caucasian patients who under- went on-pump CPB surgery Prolonged intensive care unit (ICU) stay and low Systemic Vascu-
lar Resistance Index (SVRI) after cardiopulmonary bypass (CPB) 
by interleukin (IL)-18 9545 T/G genotype in Caucasian patients 
who underwent on-pump CPB surgery. Percentage of patients hav-
ing prolonged ICU stay (greater than 72 hours) are indicated on the 
first Y-axis and percentage of patients having low SVRI after CPB sur-
gery are indicated on the second Y-axis. IL-18 9545 T/G genotypes are 
indicated on the X-axis. Patients homozygous for the T allele of the IL-
18 9545 T/G SNP had significantly greater occurrence of prolonged 
ICU stay and significantly increased occurrence of low SVRI after CPB 
compared with all others (GT and GG genotypes).Critical Care    Vol 13 No 1    Shaw et al.
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Discussion
We have identified an association between the TT genotype of
the novel 9545 T/G polymorphism of the IL-18 gene and
adverse outcome after CPB surgery. The TT genotype was
found to be associated with increased occurrence of pro-
longed ICU stay and of two consecutive SVRI measurements
less than 1800 dyne.s/cm5/m2. A biologically plausible expla-
nation for these findings is that the TT genotype of the 9545
T/G htSNP was also associated with higher serum concentra-
tion of IL-18, higher serum TNF-α concentration and lower
serum concentration of IL-10 in our cardiac surgical popula-
tion. Prolonged ICU stay is reported to be correlated with risk
factors for poor outcome after CPB surgery [11]. Low sys-
temic vascular resistance, defined as two consecutive SVRI
measurements less that 1800 dyne.s/cm5/m2, is a marker of
poor vascular tone after CPB, related to the systemic inflam-
matory response [13]. Greater serum concentrations of IL-18
[2] and TNF-α [1] and lower serum levels of IL-10 [1] have
been associated with increased prevalence of complications
after CPB, and may be indicative of a prominent pro-inflamma-
tory state.
Production of humoral inflammatory mediators and priming of
neutrophils by exposure to the CPB apparatus enables a
'post-pump' syndrome characterised by a systemic inflamma-
tory response syndrome and its anti-inflammatory counterpart,
termed the compensatory anti-inflammatory response syn-
drome [20]. IL-18 plays a central role in regulating and balanc-
ing these responses. IL-18 regulates the expression of the
potent pro- and anti-inflammatory mediators TNF-α [4] and IL-
10 [5]. In accord with this, we found that the TT genotype was
associated with an increased serum IL-18 concentration and
also with increased serum TNF-α and decreased serum IL-10.
The increased serum TNF-α and decreased serum IL-10 levels
are associated with increased organ dysfunction [10]. There-
fore, our results are consistent with the hypothesis that the IL-
18 9545 TT genotype leads to increased production of serum
IL-18, subsequently leading to increased serum TNF-α and
decreased serum IL-10, causing increased organ dysfunction
and increased occurrence of prolonged ICU stay.
Polymorphisms in the IL-18 gene have been studied for asso-
ciation with inflammatory conditions such as type 1 diabetes
[3] and sepsis [21]. The -607 C/A and -137 G/C promoter
Table 2
Logistic regression parameters. The outcome of logistic regression is shown for a model where intensive care unit (ICU) stay more 
than three days is the dependent variable (primary outcome). The covariates entered into the model were IL-18 9545 genotype, age, 
gender, duration of bypass, pre-operative ejection fraction and whether the patient had diabetes or renal dysfunction. Renal 
dysfunction was defined as baseline creatinine more than 200 μmol/L
Covariate Relative risk
of ICU stay > three days
95% confidence interval p value
IL-18 9545 TT versus TG/GG genotype 3.01 1.28 to 7.10 0.012
Age (per year) 1.01 0.98 to 1.04 0.608
Gender (female) 0.95 0.40 to 2.27 0.905
Duration of bypass (per hour) 2.09 1.49 to 2.93 0.000
Ejection fraction (per %) 0.97 0.95 to 1.0 0.026
Diabetes 1.10 0.50 to 2.43 0.806
Renal dysfunction 1.77 0.36 to 8.63 0.482
Table 3
Logistic regression parameters. The outcome of logistic regression is shown for a model where low post-cardiopulmonary bypass 
(CPB) Systemic Vascular Resistance Index (SVRI) is the dependent variable (secondary outcome). The covariates entered into the 
model were IL-18 9545 genotype, age, gender and duration of bypass.
Covariate Relative risk
of low post-CPB SVRI
95% confidence interval p value
IL-18 9545 (TT versus TG/GG genotype) 1.57 1.01 to 2.44 0.045
Age (per year) 1.01 0.98 to 1.03 0.480
Gender (female) 0.70 0.39 to 1.27 0.703
Duration of bypass (per hour) 1.03 0.66 to 1.62 0.889Available online http://ccforum.com/content/13/1/R9
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SNPs have been found to be associated with a susceptibility
to type 1 diabetes such that the C allele of -137 was found to
be a risk allele and the A allele of -607 was found to be a pro-
tective allele [3]. Polymorphisms in the IL-18 gene have also
been associated with alterations in serum concentrations of IL-
18 [22]. None of the previous literature reports an association
between the 9545 T/G SNP and outcomes, or between this
SNP and serum cytokine levels. The previous SNPs, -607 C/
A and -137 G/C are not in significant linkage disequilibrium
with the 9545 T/G SNP (Figure 1). Neither of these previously
reported SNPs were in association with our primary or sec-
ondary clinical or intermediate phenotypes.
The 9545 T/G SNP of the IL-18 gene is located within intron
2 and therefore may not be the causal SNP with regard to clin-
ical outcomes or intermediate phenotypes. Strong linkage dis-
equilibrium exists between the 9545 T/G SNP and several
other SNPs within the IL-18 gene (Figure 1): -2163 C/A
(rs5744222) in the promoter; 790 G/T (n/a) and 8936 A/G
(rs4988359) in intron 1; 11024 G/C (rs1834481), 12003 T/
C (rs5744256) and 13084 G/C (rs5744258) in intron 3; and
17980 G/C (rs5744276) in intron 5. Promoter SNPs are likely
to have an effect by disrupting or creating binding sites for
transcription factors, thus altering levels of intracellular tran-
script and/or extracellular protein [23]. The -2163 C/A SNP,
however, is not found to be located within a putative transcrip-
tion factor binding site, nor does the rare allele create one,
based on a scan of the promoter region of the IL-18 gene
using TESS (transcriptional element search software). Intronic
SNPs can affect splicing of the pre-mRNA, resulting in alterna-
tive splice variants of proteins; however, most intronic SNPs
thought to have these effects are observed to lie within about
20 bp of intron/exon boundaries [24]. The 9545 T/G SNP
itself does not lie so close to such a boundary, nor do any of
the SNPs in LD with 9545 mentioned above. Linkage disequi-
librium can carry over the putative gene boundary, and may
allow the 9545 T/G SNP to be tightly correlated with a causal
SNP up- or downstream of the IL-18 gene, one which may
have a causal effect on clinical and intermediate phenotypes.
Haplotypes represent a powerful method of selecting SNPs
for genotyping based on linkage disequilibrium. The IL-18
gene has 56 polymorphic loci in Caucasians according to
sequencing data from the University of Arizona's Innate Immu-
nity Program in Genomic Applications website. The SNPs at
positions -607 and -137 relative to the start of translation are
literature SNPs, and so make good choices for genotyping in
an inflammatory-related population such as CPB patients. The
positions 8148 and 9545 are not previously reported SNPs,
however, and so would not have been chosen for genotyping
without some method of selecting SNPs. By selecting htSNPs
to maximise information while minimising the number of SNPs
to be genotyped, we have queried the underlying haplotype
structure while using relatively few polymorphic loci. Although
this marker-style approach to disease association is useful, it
does not address mechanism or functionality of the polymor-
phism itself.
Our study has several strengths. The use of haplotypes to
choose htSNPs has the benefit of not being restricted to liter-
ature SNPs for disease association studies. The large sample
size allows for statistical power to detect associations of mod-
est effect and the limitation of sampling to Caucasians patients
reduces the likelihood of type I error due to population admix-
ture.
One of the main weaknesses of our study design is that we do
not identify the causative SNP for worse clinical outcome after
CPB. Linkage disequilibrium existing within and possibly
beyond the IL-18 gene suggests that polymorphic loci in link-
age disequilibrium with the T allele of the 9545 T/G SNP could
contribute to detrimental effects after CPB surgery. We have
limited our study to a single cohort; therefore this arising
hypothesis should be tested in other cohorts to ensure repro-
ducibility.
Conclusions
In the present study the TT genotype of a novel polymorphism
of the IL-18 gene, 9545 T/G, was associated with greater
occurrence of prolonged ICU stay after CPB surgery, greater
frequency of low SVRI (two consecutive SVRI measurements
< 1800 dyne.s/cm5/m2), higher serum concentrations of
cytokine IL-18, higher serum concentrations of the cytokine
TNF-α and lower serum concentrations of the anti-inflamma-
tory cytokine IL-10. These widely varied markers of intensity of
recovery post-CPB indicate this genotype is potentially a risk
factor for patients undergoing CPB surgery.
Figure 4
Serum concentrations of interleukin (IL)-18, tumour necrosis factor  (TNF)-α and IL-10 by IL-18 9545 T/G genotype in Caucasian patients  who underwent on-pump cardiopulmonary bypass (CPB) surgery Serum concentrations of interleukin (IL)-18, tumour necrosis fac-
tor (TNF)-α and IL-10 by IL-18 9545 T/G genotype in Caucasian 
patients who underwent on-pump cardiopulmonary bypass (CPB) 
surgery. Serum concentrations of cytokines (pg/mL) are indicated on 
the y-axes, with IL-18 9545 T/G genotype indicated in the legend. 
Serum cytokine concentrations were measured 24 hours post-CPB. 
Patients homozygous for the T allele of the IL-18 9545 T/G SNP had 
significantly higher serum IL-18 and TNF-α concentrations and signifi-
cantly lower serum IL-10 concentrations 24 hours post-CPB.Critical Care    Vol 13 No 1    Shaw et al.
Page 8 of 8
(page number not for citation purposes)
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
DS contributed to experimental design, data collection, geno-
typing and protein measurement, conducted the primary anal-
ysis of data and wrote the initial draft of the manuscript. AS
assisted in data collection, in genotyping and in protein meas-
urement. JR and SL contributed to experimental design and
data collection. KRW contributed to experimental design, data
collection and data analysis. All authors read, approved and
contributed to the final draft of the manuscript.
Acknowledgements
Supported by Canadian Institutes of Health Research and by the Heart 
and Stroke Foundation of BC & Yukon. DS and AS are the recipients of 
Michael Smith Foundation for Health Research Graduate Studentships. 
KRW is a Michael Smith Foundation for Health Research Distinguished 
Scholar.
References
1. Wan S, LeClerc JL, Schmartz D, Barvais L, Huynh CH, Deviere J,
DeSmet JM, Vincent JL: Hepatic release of interleukin-10 during
cardiopulmonary bypass in steroid-pretreated patients.  Am
Heart J 1997, 133:335-339.
2. Sablotzki A, Dehne MG, Friedrich I, Grond S, Zickmann B, Muhling
J, Silber RE, Czeslick EG: Different expression of cytokines in
survivors and non-survivors from MODS following cardiovas-
cular surgery.  Eur J Med Res 2003, 8:71-76.
3. Kretowski A, Mironczuk K, Karpinska A, Bojaryn U, Kinalski M,
Puchalski Z, Kinalska I: Interleukin-18 promoter polymorphisms
in type 1 diabetes.  Diabetes 2002, 51:3347-3349.
4. Chandrasekar B, Vemula K, Surabhi RM, Li-Weber M, Owen-
Schaub LB, Jensen LE, Mummidi S: Activation of intrinsic and
extrinsic proapoptotic signaling pathways in interleukin-18-
mediated human cardiac endothelial cell death.  J Biol Chem
2004, 279:20221-20233.
5. Takeuchi D, Yoshidome H, Kato A, Ito H, Kimura F, Shimizu H, Oht-
suka M, Morita Y, Miyazaki M: Interleukin 18 causes hepatic
ischemia/reperfusion injury by suppressing anti-inflammatory
cytokine expression in mice.  Hepatology 2004, 39:699-710.
6. Oberholzer A, Steckholzer U, Kurimoto M, Trentz O, Ertel W: Inter-
leukin-18 plasma levels are increased in patients with sepsis
compared to severely injured patients.  Shock 2001,
16:411-414.
7. Hanifi-Moghaddam P, Schloot NC, Kappler S, Seissler J, Kolb H:
An association of autoantibody status and serum cytokine lev-
els in type 1 diabetes.  Diabetes 2003, 52:1137-1142.
8. Schroeder S, Borger N, Wrigge H, Welz A, Putensen C, Hoeft A,
Stuber F: A tumor necrosis factor gene polymorphism influ-
ences the inflammatory response after cardiac operation.  Ann
Thorac Surg 2003, 75:534-537.
9. Giedraitis V, He B, Huang WX, Hillert J: Cloning and mutation
analysis of the human IL-18 promoter: a possible role of poly-
morphisms in expression regulation.  J Neuroimmunol 2001,
112:146-152.
10. Daemen MA, Ven MW van de, Heineman E, Buurman WA:
Involvement of endogenous interleukin-10 and tumor necro-
sis factor-alpha in renal ischemia-reperfusion injury.  Trans-
plantation 1999, 67:792-800.
11. Nakasuji M, Matsushita M, Asada A: Risk factors for prolonged
ICU stay in patients following coronary artery bypass grafting
with a long duration of cardiopulmonary bypass.  J Anesth
2005, 19:118-123.
12. Lawrence DR, Valencia O, Smith EE, Murday A, Treasure T: Par-
sonnet score is a good predictor of the duration of intensive
care unit stay following cardiac surgery.  Heart 2000,
83:429-432.
13. Kristof AS, Magder S: Low systemic vascular resistance state in
patients undergoing cardiopulmonary bypass.  Crit Care Med
1999, 27:1121-1127.
14. Stephens M, Donnelly P: A comparison of bayesian methods for
haplotype reconstruction from population genotype data.  Am
J Hum Genet 2003, 73:1162-1169.
15. Kumar S, Tamura K, Jakobsen IB, Nei M: MEGA2: molecular evo-
lutionary genetics analysis software.  Bioinformatics 2001,
17:1244-1245.
16. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson
DA: Selecting a maximally informative set of single-nucleotide
polymorphisms for association analyses using linkage dise-
quilibrium.  Am J Hum Genet 2004, 74:106-120.
17. Livak KJ: Allelic discrimination using fluorogenic probes and
the 5' nuclease assay.  Genet Anal 1999, 14:143-149.
18. Guo SW, Thompson EA: Performing the exact test of Hardy-
Weinberg proportion for multiple alleles.  Biometrics 1992,
48:361-372.
19. Long AD, Langley CH: The power of association studies to
detect the contribution of candidate genetic loci to variation in
complex traits.  Genome Res 1999, 9:720-731.
20. Picone AL, Lutz CJ, Finck C, Carney D, Gatto LA, Paskanik A,
Searles B, Snyder K, Nieman G: Multiple sequential insults
cause post-pump syndrome.  Ann Thorac Surg 1999,
67:978-985.
21. Stassen NA, Breit CM, Norfleet LA, Polk HC Jr: IL-18 promoter
polymorphisms correlate with the development of post-injury
sepsis.  Surgery 2003, 134:351-356.
22. Kretowski A, Kinalska I: Serum levels of interleukin-18 – a
potential marker of cardiovascular death – could be deter-
mined by genetic predisposition.  Circulation 2003,
107:e206-207. author reply e206–207.
23. Szalai AJ, Wu J, Lange EM, McCrory MA, Langefeld CD, Williams
A, Zakharkin SO, George V, Allison DB, Cooper GS, Xie F, Fan Z,
Edberg JC, Kimberly RP: Single-nucleotide polymorphisms in
the C-reactive protein (CRP) gene promoter that affect tran-
scription factor binding, alter transcriptional activity, and asso-
ciate with differences in baseline serum CRP level.  J Mol Med
2005, 83:440-447.
24. Majewski J, Ott J: Distribution and characterization of regula-
tory elements in the human genome.  Genome Res 2002,
12:1827-1836.
Key messages
￿  The TT genotype of the IL-18 9545 T/G polymorphism 
is associated with an increased occurrence of pro-
longed stay in the ICU post-surgery.
￿  The same genotype was associated with increased IL-
18 levels.
￿  The increase in IL-18 levels associated with the TT gen-
otype appeared to result in increased pro-inflammatory 
TNF-α levels and decreased anti-inflammatory IL-10 lev-
els; TNF-α and IL-10 having previously been shown to 
be regulated by IL-18 in this way.
￿  The pro-inflammatory balance (as indicated by 
increased TNF-α and decreased IL-10) may account for 
the adverse clinical outcomes associated with the TT 
genotype post surgery.